Femoston

Femoston is a hormone replacement therapy (HRT) containing estradiol and dydrogesterone. It is used to manage menopausal symptoms and support women's health during and after menopause.

Femoston is primarily used to alleviate symptoms associated with menopause, such as hot flashes, night sweats, and vaginal dryness. It combines estradiol, which replaces the estrogen that the body no longer produces in sufficient quantities, and dydrogesterone, a progestogen that supports endometrial health. This combination is often prescribed to women who have not had a hysterectomy. Femoston may also be used to prevent osteoporosis in postmenopausal women at high risk of fractures.

Common effects of Femoston may include breast tenderness, headaches, and bloating. Some users report mood changes or irregular vaginal bleeding, especially during the initial stages of treatment. These effects vary among individuals and typically subside as the body adjusts to the medication.

Femoston should be used under medical supervision. It is not suitable for everyone, particularly those with a history of breast cancer, blood clots, or liver disease. Regular check-ups are recommended to monitor for any adverse effects. Always inform your healthcare provider about any pre-existing conditions or other medications you are taking.

Femoston may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid alcohol while taking Femoston, as it can increase the risk of side effects. Always consult your healthcare provider before starting any new medication while on Femoston.